COVD-17. TUMOR TREATING FIELDS FOR GLIOBLASTOMA THERAPY DURING THE COVID-19 PANDEMIC: EXPERT CONSENSUS ON USE AND EXPERIENCE

BACKGROUND: The COVID-19 pandemic has placed excessive strain on health care systems and this is especially evident in treatment decision-making for cancer patients. Glioblastoma (GBM) patients are among the most vulnerable due to increased incidence in the elderly (median age 64 years, peak between...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Tosha Gatson, Na, Barnholtz-Sloan, Jill S, Drappatz, Jan, Henriksson, Roger, Hottinger, Andreas, Hinoul, Piet, Kruchko, Carol, Puduvalli, Vinay, Tran, David, Wong, Eric, Glas, Martin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Covid-19 and Neuro-Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650331/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.100
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak